Formoterol Fumarate Drug Combination Budesonide

A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

Also Known As:

Budesonide, Formoterol Fumarate Drug Combination; Budesonide Formoterol Drug Combination; Budesonide Formoterol Fumarate Drug Combination; Budesonide-Formoterol Drug Combination; Budesonide-Formoterol Fumarate Drug Combination; Symbicort; Combination, Budesonide-Formoterol Drug; Drug Combination, Budesonide-Formoterol

Networked: 88 relevant articles (15 outcomes, 34 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1.	O'Byrne, Paul M: 7 articles (12/2021 - 01/2004)
2.	Bateman, Eric D: 6 articles (12/2021 - 01/2003)
3.	Reddel, Helen K: 6 articles (12/2021 - 03/2010)
4.	Barnes, Peter J: 5 articles (12/2021 - 12/2011)
5.	FitzGerald, J Mark: 5 articles (12/2021 - 11/2003)
6.	Buhl, Roland: 5 articles (02/2012 - 08/2003)
7.	Sears, Malcolm R: 4 articles (04/2011 - 11/2003)
8.	Kuna, Piotr: 4 articles (01/2010 - 06/2003)
9.	Lamarca, Rosa: 3 articles (12/2021 - 01/2021)
10.	Puu, Margareta: 3 articles (12/2021 - 01/2021)

Related Diseases

1.	Asthma (Bronchial Asthma) 01/01/2009 - "Symbicort SMART delivers improved asthma outcomes with lower treatment and social costs than any alternative." 01/01/2009 - "Current control of asthma symptoms is improved or achieved with reduced total dose administration with Symbicort SMART compared with any reasonable alternate option. " 10/23/2023 - "Inputs were derived from the SYmbicort Given as-needed in Mild Asthma (SYGMA) trials, published literature, and commercial costs. " 01/01/2022 - "SYmbicort given as needed in mild asthma (SYGMA study): a retrospective subanalysis of the Russian population." 01/01/2021 - "In this post-hoc analysis of the SYmbicort Given as needed in Mild Asthma (SYGMA) 1 study, we investigated the short-term risk of severe exacerbations after a single day with various levels of reliever use. "
2.	Inflammation (Inflammations) 06/01/2007 - "The positive results with Symbicort SMART can be explained by the early as-needed use on the inhaled corticosteroid component, which puts out the early flames of inflammation, together with the interaction between the beta(2)-agonist, formoterol, and the inhaled corticosteroid, budesonide."
3.	Chronic Obstructive Pulmonary Disease (COPD) 01/01/2008 - "In COPD, Symbicort offers clinical advantages over therapy with the monocomponents and these are achieved at little or no extra cost." 01/01/2008 - "A total of 13 studies on Symbicort in asthma and 2 studies on Symbicort in COPD were found. " 03/01/2004 - "Are Seretide and Symbicort useful in COPD?" 10/01/2014 - "Inspiratory flow parameters via EH and Symbicort(®) Turbuhaler(®) (TH) inhalers were evaluated in 187 patients with asthma and COPD. " 10/10/2016 - "One of the most widespread dry powder fixed combinations used in asthma and chronic obstructive pulmonary disease (COPD) management is Symbicort(®) Turbuhaler(®). "
4.	Airway Remodeling 04/01/2008 - "We also investigated the effect of treatment with budesonide/formoterol (Symbicort; AstraZeneca, Lund, Sweden) in the relationship between VEGF and airway remodelling. "
5.	Gastroschisis 05/01/2021 - "Anti-asthma Drugs Formoterol and Budesonide (Symbicort) Induce Orofacial Clefts, Gastroschisis and Heart Septum Defects in an In Vivo Model."

Related Drugs and Biologics

1.	Formoterol Fumarate (Oxis)
2.	Budesonide (Pulmicort)
3.	Adrenal Cortex Hormones (Corticosteroids)
4.	Fluticasone-Salmeterol Drug Combination (Advair)
5.	Fluticasone (Cutivate)
6.	Bronchodilator Agents (Bronchodilators)
7.	Salmeterol Xinafoate (Serevent)
8.	Tiotropium Bromide (Spiriva)
9.	Nitric Oxide (Nitrogen Monoxide)
10.	Muscarinic Antagonists

Related Therapies and Procedures

1.	Nebulizers and Vaporizers (Inhaler)
2.	Therapeutics
3.	Tracheostomy
4.	Metered Dose Inhalers (Metered Dose Inhaler)
5.	Dry Powder Inhalers